307 related articles for article (PubMed ID: 25747517)
21. Influences on human papillomavirus vaccination status among female college students.
Daley EM; Vamos CA; Buhi ER; Kolar SK; McDermott RJ; Hernandez N; Fuhrmann HJ
J Womens Health (Larchmt); 2010 Oct; 19(10):1885-91. PubMed ID: 20815737
[TBL] [Abstract][Full Text] [Related]
22. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.
Ylitalo KR; Lee H; Mehta NK
Am J Public Health; 2013 Jan; 103(1):164-9. PubMed ID: 22698055
[TBL] [Abstract][Full Text] [Related]
23. Do correlates of HPV vaccine initiation differ between adolescent boys and girls?
Gilkey MB; Moss JL; McRee AL; Brewer NT
Vaccine; 2012 Sep; 30(41):5928-34. PubMed ID: 22841973
[TBL] [Abstract][Full Text] [Related]
24. Factors Associated With Parents' Intent to Vaccinate Adolescents for Human Papillomavirus: Findings From the 2014 National Immunization Survey-Teen.
Mohammed KA; Vivian E; Loux TM; Arnold LD
Prev Chronic Dis; 2017 Jun; 14():E45. PubMed ID: 28595031
[TBL] [Abstract][Full Text] [Related]
25. Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.
Fu LY; Zimet GD; Latkin CA; Joseph JG
Vaccine; 2017 Feb; 35(5):802-807. PubMed ID: 28063706
[TBL] [Abstract][Full Text] [Related]
26. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
27. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth.
Liddon NC; Hood JE; Leichliter JS
Vaccine; 2012 Mar; 30(16):2676-82. PubMed ID: 22342548
[TBL] [Abstract][Full Text] [Related]
28. Racial/ethnic disparities in human papillomavirus vaccination initiation and completion among U.S. women in the post-Affordable Care Act era.
Agénor M; Pérez AE; Peitzmeier SM; Borrero S
Ethn Health; 2020 Apr; 25(3):393-407. PubMed ID: 29347831
[No Abstract] [Full Text] [Related]
29. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.
Newcomer SR; Caringi J; Jones B; Coyle E; Schehl T; Daley MF
Public Health Rep; 2020; 135(6):842-850. PubMed ID: 32972304
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and predictors of human papillomavirus vaccination in adolescent girls.
Palli SR; Mehta S; Aparasu RR
J Am Pharm Assoc (2003); 2012; 52(1):52-8. PubMed ID: 22257616
[TBL] [Abstract][Full Text] [Related]
31. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
[TBL] [Abstract][Full Text] [Related]
32. The relationship between receiving care within a medical home and HPV vaccine receipt for adolescent girls: results of the 2007 National Survey of Children's Health.
Sara Test F; Caskey R; Rankin KM
Matern Child Health J; 2013 Feb; 17(2):274-81. PubMed ID: 22415810
[TBL] [Abstract][Full Text] [Related]
33. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study.
Perkins RB; Brogly SB; Adams WG; Freund KM
J Womens Health (Larchmt); 2012 Aug; 21(8):813-20. PubMed ID: 22860770
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.
Lau M; Lin H; Flores G
Vaccine; 2012 Apr; 30(20):3112-8. PubMed ID: 22425179
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus (HPV) vaccine initiation in minority Americans.
De P; Budhwani H
Public Health; 2017 Mar; 144():86-91. PubMed ID: 28274389
[TBL] [Abstract][Full Text] [Related]
36. Unequal interactions: Examining the role of patient-centered care in reducing inequitable diffusion of a medical innovation, the human papillomavirus (HPV) vaccine.
Fenton AT; Elliott MN; Schwebel DC; Berkowitz Z; Liddon NC; Tortolero SR; Cuccaro PM; Davies SL; Schuster MA
Soc Sci Med; 2018 Mar; 200():238-248. PubMed ID: 29157686
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.
Lai D; Ding Q; Bodson J; Warner EL; Kepka D
Public Health Nurs; 2016 Jul; 33(4):283-94. PubMed ID: 26331614
[TBL] [Abstract][Full Text] [Related]
38. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).
Hirth JM; Fuchs EL; Chang M; Fernandez ME; Berenson AB
Vaccine; 2019 Jan; 37(4):595-601. PubMed ID: 30580838
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.
Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS
J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327
[TBL] [Abstract][Full Text] [Related]
40. Provider communication and HPV vaccination: The impact of recommendation quality.
Gilkey MB; Calo WA; Moss JL; Shah PD; Marciniak MW; Brewer NT
Vaccine; 2016 Feb; 34(9):1187-92. PubMed ID: 26812078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
